ANNUAL REPORT

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

June 21, 2013

Period of Report

March 31, 2013

Accession Number

0001144204-13-036025

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →